Neurodegenerative diseases such as AD, PD, MSA, etc. are the main focus of ATH. How they relate to other types of diseases is interesting, IMO. Strangely, AD patients and PD patients' risk of getting type 2 diabetes is elevated but there are differences. The list of "lower odds" is interesting in the paper above. I do not think it is similar to the corresponding list in PD. So this paper is general info about neurodegenerative diseases.
Neurodegenerative diseases such as AD, PD, MSA, etc. are the...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $10.07K | 3.191M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 22568002 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 127369917 | 27 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |